Adenosine Injection IP

Trade Name: AdenCure
Available Strength : 6 mg
Available Combination : Adenosine Injection IP is used in the management of supraventricular tachycardia and may be combined with cardiac monitoring and supportive care to rapidly restore normal heart rhythm by temporarily slowing atrioventricular conduction.
Packing : 2 ml Amp.
Pack Insert/Leaflet : YES
Therapeutic use : Adenosine Injection IP is used in the management of supraventricular tachycardia and may be combined with cardiac monitoring and supportive care to rapidly restore normal heart rhythm by temporarily slowing atrioventricular conduction.
Capacity : 100000

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.